Literature DB >> 19059112

Technique for prolonged normothermic ex vivo lung perfusion.

Marcelo Cypel1, Jonathan C Yeung, Shin Hirayama, Matthew Rubacha, Stefan Fischer, Masaki Anraku, Masaaki Sato, Stephen Harwood, Andrew Pierre, Thomas K Waddell, Marc de Perrot, Mingyao Liu, Shaf Keshavjee.   

Abstract

BACKGROUND: The inhibition of cellular metabolism induced by hypothermia obviates the possibility of substantial reparative processes occurring during organ preservation. The aim of this study was to develop a technique of extended (12-hour) ex vivo lung perfusion (EVLP) at normothermia for assessment and protective maintenance of the donor lung.
METHODS: Six double-lung blocks from 35-kg pigs and 5 single human lungs were subjected to 12 hours of normothermic EVLP using acellular Steen Solution. In the animal studies, the left lung was transplanted into recipients at the end of EVLP and reperfused for 4 hours to evaluate the impact of prolonged EVLP on post-transplant lung function. A protective mode of mechanical ventilation with controlled perfusion flows and pressures in the pulmonary vasculature were employed during EVLP. Lung oxygenation capacity (DeltaPo(2)), pulmonary vascular resistance and airway pressures were evaluated in the system. Red blood cells were added to the perfusate to a hematocrit of 20% at the end of human lung EVLP to study lung functional assessment with and without cells.
RESULTS: Lung function was stable during 12 hours of EVLP. This stability during prolonged normothermic EVLP translated into excellent post-transplant lung function (Pao(2)/Fio(2): 527 +/- 22 mm Hg), low edema formation (wet/dry ratio: 5.24 +/- 0.38) and preserved lung histology after transplantation. The acellular perfusion assessment of lung function accurately correlated with post-transplant graft function.
CONCLUSIONS: Twelve hours of EVLP at physiologic temperatures using an acellular perfusate is achievable and maintains the donor lungs without inflicting significant added injury. This system can be used to assess, maintain and treat injured donor lungs.

Entities:  

Mesh:

Year:  2008        PMID: 19059112     DOI: 10.1016/j.healun.2008.09.003

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  103 in total

1.  Reduced-flow ex vivo lung perfusion to rehabilitate lungs donated after circulatory death.

Authors:  Jared P Beller; Matthew R Byler; Dustin T Money; William Z Chancellor; Aimee Zhang; Yunge Zhao; Mark H Stoler; Adishesh K Narahari; Alexander Shannon; J Hunter Mehaffey; Curtis G Tribble; Victor E Laubach; Irving L Kron; Mark E Roeser
Journal:  J Heart Lung Transplant       Date:  2019-09-18       Impact factor: 10.247

2.  Revisiting successful transplantation with marginal lungs: Fourteen years later, a new era of extended criteria.

Authors:  J Hunter Mehaffey; Robert B Hawkins; Eric J Charles; Curtis G Tribble
Journal:  J Thorac Cardiovasc Surg       Date:  2016-08-29       Impact factor: 5.209

Review 3.  Preservation solution for lung transplantation.

Authors:  Yoshinori Okada; Takashi Kondo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-12

Review 4.  Non-heart-beating donation in Spain.

Authors:  David Gomez-de-Antonio; Andres Varela
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-01-12

Review 5.  Ex vivo lung perfusion prior to transplantation: an overview of current clinical practice worldwide.

Authors:  Julien Possoz; Arne Neyrinck; Dirk Van Raemdonck
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

6.  In vivo lung perfusion as a platform for organ repair in acute respiratory distress syndrome.

Authors:  Khaled Ramadan; Lorenzo Del Sorbo; Marcelo Cypel
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

Review 7.  Bioengineering approaches to organ preservation ex vivo.

Authors:  Meghan Pinezich; Gordana Vunjak-Novakovic
Journal:  Exp Biol Med (Maywood)       Date:  2019-03-19

Review 8.  [Therapy escalation for the potential organ donor : Are all intensive care measures also ethically justifiable?]

Authors:  S-O Kuhn; K Hahnenkamp
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-07-26       Impact factor: 0.840

9.  Ex Vivo Lung Perfusion Rehabilitates Sepsis-Induced Lung Injury.

Authors:  J Hunter Mehaffey; Eric J Charles; Ashish K Sharma; Morgan Salmon; Dustin Money; Sarah Schubert; Mark H Stoler; Curtis G Tribble; Victor E Laubach; Mark E Roeser; Irving L Kron
Journal:  Ann Thorac Surg       Date:  2017-04-21       Impact factor: 4.330

10.  Human models of acute lung injury.

Authors:  Alastair G Proudfoot; Danny F McAuley; Mark J D Griffiths; Matthew Hind
Journal:  Dis Model Mech       Date:  2011-03       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.